The major factors driving the growth of Breast Biopsy Devices Market include the growing prevalent cases of breast cancer, the increasing number of breast cancer screening programs, the growing demand for minimally invasive and non-invasive procedures, and the improved reimbursement scenario.
What
the Market Looks Like?
Breast
Biopsy Devices Market is projected to reach USD 2.6 billion by 2028 from USD 1.6
billion in 2023, at a CAGR of 10.0% from 2023 to 2028.
Download
PDF Brochure: -https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=189011805
Market
Segmentation: -
Based on the type, the global breast biopsy devices market is
segmented into biopsy needles, guidance systems, localization wires, assay
kits, liquid biopsy instruments, biopsy tables, and other devices. The assay
kits segment is expected to grow at the highest CAGR during the forecast
period.
Based on the procedure, the breast biopsy devices market is
segmented into needle open surgical breast biopsy, breast biopsy, and liquid
breast. The liquid breast biopsy segment is anticipated to register the highest
growth rate over the forecast period.
Based on application, the market is segmented into early cancer
screening, therapy selection, treatment monitoring, and recurrence monitoring.
Early cancer screening accounted for the largest share of the market in 2022.
However, the therapy selection segment is expected to grow at the highest CAGR
during the forecast period.
Based on the end user, the breast biopsy devices market is
segmented into hospitals & surgical centers, breast care centers, and
imaging clinics & diagnostic centers. The hospitals & surgical centers
segment accounts for the largest share of the market in 2022.
What
Drives the Market?
The growth of the
global market for Breast Biopsy is primarily influenced by the
following factors:
1 Growing incidence of breast cancer
2 Increasing number of breast cancer screening programs
3 Increasing demand for minimally invasive and non-invasive procedures
4 Growing awareness regarding early detection of breast cancer
5 Improved reimbursement scenario.
Regional
Analysis: -
The North American breast biopsy devices market is estimated to
grow significantly from 2023 to 2028. factors such as ongoing technological
advancements, rising breast cancer incidence rates, favorable reimbursement
scenarios, and new breast density notification laws drive market growth in
North America. This region has a rise in healthcare investment and expenditure,
offering significant growth opportunities for the key players.
Get
Data as per your Format and Definition | REQUEST FOR CUSTOMIZATION: https://www.marketsandmarkets.com/requestCustomizationNew.asp?id=189011805
Recent Developments:
- Hologic, Inc, an innovative medical
technology company primarily focused on improving women’s health,
announced today that it has completed the purchase of SOMATEX Medical
Technologies GmbH; the deal size is $64 million.
- In 2022 Danaher Corporation launched
Mammotome Revolve EX Dual Vacuum-Assisted Breast Biopsy System, the first
vacuum-assisted biopsy device designed specifically for the excision of
benign breast lesions and is twice as fast as traditional vacuum-assisted
breast biopsy systems.
- Argon Medical Devices announced the
launch of the SuperCore advantage semi-automatic biopsy instrument’s
newest addition to its soft tissue biopsy product portfolio in the united
states. The next-generation soft tissue biopsy instrument provides a
superior volume of tissue samples. Collecting more tissue volume may
increase the likelihood of an accurate diagnosis.
Top
Key Players: -
As
of 2022, prominent players in the breast biopsy devices market are Hologic Inc.
(US), Danaher Corporation (US), Argon Medical Devices (US), Medtronic (IRL),
Merit Medical Systems (US), Menarini-Silicon Biosystems (ITL), Varian
Medical Systems, Inc. (Germany), Planmed Oy (Finland), Sterylab S.R.L (Italy),
Biocept, Inc. (US), Bio-Rad Laboratories, Inc. (US), F. Hoffmann-La Roche Ltd
(Switzerland), Qiagen (Germany) and Exact Sciences Corporation (US).
The
breast biopsy devices market is highly competitive, with several key players
globally. Market dynamics, such as technological advancements, regulatory
changes, and the evolving healthcare landscape, can impact the growth and
development of this market.
No comments:
Post a Comment